AU2002219964A1 - Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose - Google Patents

Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose

Info

Publication number
AU2002219964A1
AU2002219964A1 AU2002219964A AU2002219964A AU2002219964A1 AU 2002219964 A1 AU2002219964 A1 AU 2002219964A1 AU 2002219964 A AU2002219964 A AU 2002219964A AU 2002219964 A AU2002219964 A AU 2002219964A AU 2002219964 A1 AU2002219964 A1 AU 2002219964A1
Authority
AU
Australia
Prior art keywords
coprocessed
active agent
microcrystalline cellulose
agglomerated particles
particles including
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002219964A
Other languages
English (en)
Inventor
Wilhelm Berkulin
David Schaible
Robert Sherwood
Karl-Hans Theissing
Joseph A. Zeleznik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penwest Pharmaceuticals Co
Original Assignee
Penwest Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penwest Pharmaceuticals Co filed Critical Penwest Pharmaceuticals Co
Publication of AU2002219964A1 publication Critical patent/AU2002219964A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU2002219964A 2001-11-29 2001-11-29 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose Abandoned AU2002219964A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/044928 WO2003047551A1 (fr) 2001-11-29 2001-11-29 Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee

Publications (1)

Publication Number Publication Date
AU2002219964A1 true AU2002219964A1 (en) 2003-06-17

Family

ID=21743033

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002219964A Abandoned AU2002219964A1 (en) 2001-11-29 2001-11-29 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose

Country Status (3)

Country Link
EP (1) EP1509204A4 (fr)
AU (1) AU2002219964A1 (fr)
WO (1) WO2003047551A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2008035354A1 (fr) * 2006-09-21 2008-03-27 Unijules Life Sciences Ltd. Pastilles d'extraits d'herbes et son procédé de préparation
WO2008059522A2 (fr) * 2006-09-28 2008-05-22 Unijules Life Sciences Ltd Formes posologiques d'administration contrôlée de médicament gastro-intestinale à base d'herbe comprenant des pastilles et leur procédé de préparation
SG183059A1 (en) 2007-02-23 2012-08-30 Gilead Sciences Inc Modulators of pharmacokinetic properties of therapeutics
CH698627B1 (de) * 2007-08-16 2009-09-15 Alpinia Laudanum Inst Of Phytopharmaceutical Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.
DE102007045686A1 (de) * 2007-09-24 2009-04-02 J. Rettenmaier & Söhne Gmbh + Co. Kg Verfahren zur Herstellung frei fließender, pulverförmiger Extrakte mit Hilfe der Wirbelschicht Trocknung
PL2296633T3 (pl) 2008-05-02 2016-03-31 Gilead Sciences Inc Zastosowanie cząsteczek stałych nośników dla udoskonalenia przetwarzalności środka farmaceutycznego
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
CN104472880B (zh) * 2014-12-12 2017-09-01 四川乾坤生物科技有限公司 一种兽药组合物及其制备方法和用途
EP3256141A1 (fr) 2015-02-09 2017-12-20 Vereeken, Jose Formulation multiparticulaire comprenant des extraits de plante
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212952A1 (fr) 2019-04-17 2020-10-22 Compass Pathfinder Limited Traitement de la dépression et de divers autres troubles au moyen de psilocybine
CA3225065A1 (fr) 2021-07-10 2023-01-19 Denny Johan Marijn Van Den Heuvel Formulations de composes de nicorandil a liberation modifiee

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
WO1999063969A1 (fr) * 1998-06-08 1999-12-16 Groenewoud Pieter J Medicaments a base de thyroxine stabilisee
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form

Also Published As

Publication number Publication date
WO2003047551A1 (fr) 2003-06-12
EP1509204A1 (fr) 2005-03-02
EP1509204A4 (fr) 2005-07-13

Similar Documents

Publication Publication Date Title
AU2002219964A1 (en) Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
AU2002230071A1 (en) Complex carbohydrate arrays and methods for the manufacture and uses thereof
AU2001235998A1 (en) Reagents for the quantitation of active oxygen
AU2002352850A1 (en) Channelized sorbent media, and methods of making same
AU2002329873A1 (en) Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
AU2002231721A1 (en) Stabilizer based on microcrystalline cellulose for drink and dressing formulations
AUPR381201A0 (en) Improved pivot assemblies
AU2002349882A1 (en) Q4n2neg2 enhances cftr activity
AU2002233229A1 (en) Method for producing dimensionally stable, spherical carbohydrate particles and the use thereof
AU2002320942A1 (en) Flame-proofing agent and means for the production thereof
AU2002346252A1 (en) Particle probe
AU2003256475A1 (en) Wide dynamic range operational amplifier
AU2003205791A1 (en) Active substance diffuser
AU2002250977A1 (en) Combination of active ingredients consisting of the racemate of tramadol and of (+)-o-desmethyltramadol
AU2003263329A1 (en) Foxp2 and uses thereof
AU2002234219A1 (en) Granular composition comprising an active compound and a cellulose ether and the use thereof
AU2002324660A1 (en) Earplug with stiffener
AUPR977601A0 (en) Defective entities and uses therefor
AU2003902788A0 (en) Active compounds and uses therefor
AU2001237164A1 (en) Caspase-inhibitory-factor (cif) and uses thereof
AU2002245209A1 (en) Microcrystalline cellulose manufacture
AU2002306334A1 (en) Particle pulverizer
AU2002236402A1 (en) Earmuff with earphone
AU2002239893A1 (en) Systems and methods providing dynamic spreadsheet functionality
AU2002345460A1 (en) Active filter

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase